Who Supplies Celecoxib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Celecoxib exports, with 326+ registered manufacturers shipping to buyers across 112+ countries — yet a handful of companies dominate the shipments. UMEDICA LABORATORIES PRIVATE LIMITED holds the largest share at 17.8% (export value: $23.7M). Close behind, MACLEODS PHARMACEUTICALS LTD (12.1%, $16.1M). ALEMBIC PHARMACEUTICALS LIMITED (6.6%, $8.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Celecoxib? Top Manufacturers & Their Buyers
Flow of Celecoxib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Celecoxib Supplier Network — Key Market Intelligence
The Celecoxib export market from India is led by UMEDICA LABORATORIES PRIVATE LIMITED, which alone commands a 17.8% share, shipping $23.7M worth of product across 65 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $16.1M (12.1%) to the overall market. Combined, the top two suppliers alone account for 29.8% of all Celecoxib exports, indicating a relatively concentrated supply base.
Across all 326 tracked manufacturers, the total Celecoxib export value stands at $133.6M from 4.9K shipments. The market average shipment value is $27.4K. The single largest buyer relationship in terms of trade value is LIFESCIENCE LOGISTICS, receiving $23.5M worth of product.
The combined buyer network spans 17 named purchasing companies, including LIFESCIENCE LOGISTICS, NIVAGEN PHARMA, Life Science Logisti, MACLEODS PHARMA USA ,INC, CONTROLLED MEDICATIONS LTD and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1UMEDICA LABORATORIES PRIVATE LIMITED
UMEDICA LABORATORIES PRIVATE LIMITED is the first-largest Celecoxib exporter from India, with a market share of 17.8% and a total export value of $23.7M across 65 shipments. Their average shipment value of $364.9K is above the market average of $27.4K, suggesting premium or bulk contract pricing.
UMEDICA LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. LIFESCIENCE LOGISTICS is the dominant customer, accounting for 99.3% of this supplier's tracked business. Top customers include:
• LIFESCIENCE LOGISTICS — $23.5M across 65 shipments (99.3% of this supplier's total exports)
• NIVAGEN PHARMA — $92.8K across 0 shipments (0.4% of this supplier's total exports)
• Life Science Logisti — $46.0K across 0 shipments (0.2% of this supplier's total exports)
• LIFESCIENCE LOGISTICS — $27.1K across 0 shipments (0.1% of this supplier's total exports)
• TO THE ORDER — $9.0K across 0 shipments (0.0% of this supplier's total exports)
Key Insight: UMEDICA LABORATORIES PRIVATE LIMITED's per-shipment value of $364.9K is 1233% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Celecoxib exporter from India, with a market share of 12.1% and a total export value of $16.1M across 184 shipments. Their average shipment value of $87.6K is above the market average of $27.4K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMA USA ,INC is the dominant customer, accounting for 84.8% of this supplier's tracked business. Top customers include:
• MACLEODS PHARMA USA ,INC — $13.7M across 156 shipments (84.8% of this supplier's total exports)
• CONTROLLED MEDICATIONS LTD — $1.7M across 20 shipments (10.7% of this supplier's total exports)
• MACLEODS PHARMA USA ,INC — $347.8K across 4 shipments (2.2% of this supplier's total exports)
• MACLEODS PHARMA UK L — $198.0K across 2 shipments (1.2% of this supplier's total exports)
• PHARMACEUTICAL AND C — $187.4K across 2 shipments (1.2% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $87.6K is 220% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.
3ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Celecoxib exporter from India, with a market share of 6.6% and a total export value of $8.8M across 434 shipments. Their average shipment value of $20.2K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• J. KNIPPER & COMPANY, — $3.7M across 185 shipments (42.6% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $2.2M across 110 shipments (25.4% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $1.4M across 67 shipments (15.4% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $1.0M across 50 shipments (11.5% of this supplier's total exports)
• ALEMBIC PHARMACEUTIC — $439.3K across 22 shipments (5.0% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (434 shipments) at a per-shipment value of $20.2K, indicating a broad distribution network with many smaller, regular orders.
4CIPLA LIMITED
CIPLA LIMITED is the fourth-largest Celecoxib exporter from India, with a market share of 5.2% and a total export value of $6.9M across 384 shipments. Their average shipment value of $18.0K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $3.4M across 187 shipments (48.8% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.4M across 76 shipments (19.7% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.2M across 66 shipments (17.1% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $706.1K across 39 shipments (10.2% of this supplier's total exports)
• PRIORITY HEALTHCARE — $291.8K across 16 shipments (4.2% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (384 shipments) at a per-shipment value of $18.0K, indicating a broad distribution network with many smaller, regular orders.
5BDH HEALTHCARE PRIVATE LIMITED
BDH HEALTHCARE PRIVATE LIMITED is the fifth-largest Celecoxib exporter from India, with a market share of 2.8% and a total export value of $3.7M across 23 shipments. Their average shipment value of $161.7K is above the market average of $27.4K, suggesting premium or bulk contract pricing.
BDH HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. NELPA LIFESCIENCES INC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• NELPA LIFESCIENCES INC — $3.7M across 23 shipments (100.0% of this supplier's total exports)
Key Insight: BDH HEALTHCARE PRIVATE LIMITED's per-shipment value of $161.7K is 490% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Celecoxib exporter from India, with a market share of 2.2% and a total export value of $2.9M across 201 shipments. Their average shipment value of $14.7K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E.P.DIS — $1.1M across 75 shipments (37.3% of this supplier's total exports)
• AL-KAWKAB SCIENTIFIC — $667.0K across 45 shipments (22.6% of this supplier's total exports)
• E.P.DIS — $503.4K across 34 shipments (17.1% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES, LLC — $348.4K across 24 shipments (11.8% of this supplier's total exports)
• MICRO LABS GMBH — $330.2K across 23 shipments (11.2% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (201 shipments) at a per-shipment value of $14.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Celecoxib Flows
Once Celecoxib leaves the manufacturing plants of companies like UMEDICA LABORATORIES PRIVATE LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $133.6M. United States absorbs the largest share at 49.9% ($66.7M), followed by Philippines (10.2%) and Canada (5.3%).
In United States — the top destination — named importers include LIFESCIENCE LOGISTICS, MACLEODS PHARMA USA ,INC, CIPLA USA INC UPS SUPPLY CHAIN SOLU. In Philippines, key buyers are NELPA LIFESCIENCES INC.
This geographic spread reflects Celecoxib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Celecoxib Go? Top Importing Countries & Their Buyers
Trade flow of Celecoxib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Celecoxib imports from India, with a total trade value of $66.7M across 794 shipments — representing a 49.9% share of all Celecoxib exports. The average shipment value of $84.0K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Celecoxib importers in United States: LIFESCIENCE LOGISTICS is the largest buyer, accounting for 37.0% ($24.7M) of this market's total imports.
• LIFESCIENCE LOGISTICS — $24.7M (37.0% of United States's total)
• MACLEODS PHARMA USA ,INC — $13.7M (20.5% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $5.7M (8.6% of United States's total)
Key Insight: United States's per-shipment average of $84.0K (207% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Celecoxib imports from India.
2Philippines
Philippines ranks as the second-largest destination for Celecoxib imports from India, with a total trade value of $13.7M across 68 shipments — representing a 10.2% share of all Celecoxib exports. The average shipment value of $201.1K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Celecoxib importers in Philippines: NELPA LIFESCIENCES INC is the largest buyer, accounting for 76.2% ($10.4M) of this market's total imports.
• NELPA LIFESCIENCES INC — $10.4M (76.2% of Philippines's total)
Key Insight: Philippines's per-shipment average of $201.1K (634% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Celecoxib imports from India.
3Canada
Canada ranks as the third-largest destination for Celecoxib imports from India, with a total trade value of $7.1M across 110 shipments — representing a 5.3% share of all Celecoxib exports. The average shipment value of $64.2K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Celecoxib importers in Canada: APOTEX INC, is the largest buyer, accounting for 21.6% ($1.5M) of this market's total imports.
• APOTEX INC, — $1.5M (21.6% of Canada's total)
• MARCAN PHARMACEUTICALS INC. — $1.0M (14.6% of Canada's total)
Key Insight: Canada's per-shipment average of $64.2K (134% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Celecoxib imports from India.
4France
France ranks as the fourth-largest destination for Celecoxib imports from India, with a total trade value of $3.4M across 36 shipments — representing a 2.6% share of all Celecoxib exports. The average shipment value of $95.2K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Celecoxib importers in France: E.P.DIS is the largest buyer, accounting for 46.4% ($1.6M) of this market's total imports.
• E.P.DIS — $1.6M (46.4% of France's total)
Key Insight: France's per-shipment average of $95.2K (248% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Celecoxib imports from India.
5Germany
Germany ranks as the fifth-largest destination for Celecoxib imports from India, with a total trade value of $3.1M across 41 shipments — representing a 2.3% share of all Celecoxib exports. The average shipment value of $75.3K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Celecoxib importers in Germany: MERCKLE GMBH is the largest buyer, accounting for 56.5% ($1.7M) of this market's total imports.
• MERCKLE GMBH — $1.7M (56.5% of Germany's total)
Key Insight: Germany's per-shipment average of $75.3K (175% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Celecoxib imports from India.
People Also Ask — Celecoxib Supplier & Trade Network
Who are the top suppliers of Celecoxib from India?+
Which companies buy Celecoxib from Indian manufacturers?+
Where does Celecoxib exported from India go?+
What is the market share of the top Celecoxib supplier from India?+
What is the average shipment value for Celecoxib exports from India?+
Is Celecoxib manufactured in India and exported globally?+
Which country imports the most Celecoxib from India?+
Who are the buyers of Celecoxib in Philippines?+
How concentrated is the Celecoxib supplier market in India?+
How do I find verified buyers for Celecoxib in specific countries?+
Celecoxib Trade Network — Key Takeaways
- 1UMEDICA LABORATORIES PRIVATE LIMITED is India's dominant Celecoxib exporter with a 17.8% market share and $23.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 326 suppliers collectively account for 46.5% of all tracked Celecoxib exports, with a combined trade value of $133.6M.
- 3United States is the largest destination market, absorbing 49.9% of India's Celecoxib exports ($66.7M). Philippines (10.2%) and Canada (5.3%) follow.
- 4With 4.9K total shipments averaging $27.4K each, the Celecoxib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include LIFESCIENCE LOGISTICS, NIVAGEN PHARMA, MACLEODS PHARMA USA ,INC, CONTROLLED MEDICATIONS LTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 112 countries
Network value: $133.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Celecoxib.
- 2.Flow Mapping: 326 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,880 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 112 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,880 Verified Shipments
326 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists